Priority Date: 08.05.03 (US 20030469211P)

Therapeutic use of anti-CS1 antibodies

  • Application ID: EP14178061
  • Status: The patent has been granted


Technology company logo small
Technology Company


no operation time available
Headquarter in London and 4 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing


This EP application has the IPC class A61, C07, and C12. J A Kemp is specialized in the combination A61, C07, and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 134 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.


  • 08.05.2003 - Priority Date (US 20030469211P)
  • 01.04.2015 - Publication A1 (EP2853272)
  • 02.08.2017 - Publication B1 (EP2853272)